49722008: Somatostatin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\...

\Peptide hormone\Somatostatin

\Hypothalamic inhibiting factor\Somatostatin

\Gastrointestinal hormone\Somatostatin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Peptide hormone\Somatostatin

\Hypothalamic inhibiting factor\Somatostatin

\Gastrointestinal hormone\Somatostatin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Peptide hormone\Somatostatin

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Peptide hormone\Somatostatin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Somatostatin	Is a	Gastrointestinal hormone	true	Inferred relationship	Some
Somatostatin	Is a	Hypothalamic inhibiting factor	true	Inferred relationship	Some
Somatostatin	Is a	Peptidhormoner og deres metabolitter og forstadier	false	Inferred relationship	Some
Somatostatin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hypothalamic inhibiting factor (disposition)	true	Inferred relationship	Some
Somatostatin	Is a	Peptide hormone	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Octreotide	Is a	False	Somatostatin	Inferred relationship	Some
Somatostatin-14	Is a	False	Somatostatin	Inferred relationship	Some
Somatostatin-28	Is a	False	Somatostatin	Inferred relationship	Some
Somatostatin measurement	Has measured component	False	Somatostatin	Inferred relationship	Some
Somatostatin antigen	Direct substance	False	Somatostatin	Inferred relationship	Some
Serum somatostatin measurement	Has measured component	False	Somatostatin	Inferred relationship	Some
Somatostatin measurement	Component	True	Somatostatin	Inferred relationship	Some	1
Serum somatostatin measurement	Component	False	Somatostatin	Inferred relationship	Some	2
lanreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Lanreotide acetate 38mg injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Plasma somatostatin level (procedure)	Component	False	Somatostatin	Inferred relationship	Some	2
Product containing somatostatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Somatostatin	Inferred relationship	Some	1
Product containing somatostatin analog (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 50 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 100 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 500 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 200 µg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 10 mg pulver og solvens til injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 20 mg pulver og solvens til injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Product containing lanreotide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Product containing octreotide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
lanreotid 60 mg/0,3 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
lanreotid 90 mg/0,3 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
lanreotid 120 mg/0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 20mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 10mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 30mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 1mg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 100mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 200mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 500mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Octreotide acetate 50mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Lanreotide acetate 30mg/vial injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 1 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
octreotid 1 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Product containing octreotide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
lanreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Product containing somatostatin analog (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Somatostatin	Inferred relationship	Some
Somatostatin acetate (substance)	Is a	False	Somatostatin	Inferred relationship	Some
Somatostatin acetate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Somatostatin	Inferred relationship	Some
Somatostatin-28	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Somatostatin	Inferred relationship	Some
Product containing only somatostatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Somatostatin	Inferred relationship	Some	1
Plasma somatostatin level (procedure)	Component	True	Somatostatin	Inferred relationship	Some	1
Serum somatostatin measurement	Component	True	Somatostatin	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
82812011	Somatotropin release inhibiting factor	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
82813018	Somatostatin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
82814012	Growth hormone inhibiting factor	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
787432017	Somatostatin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1230764012	Growth hormone release inhibiting hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1230765013	SS - Somatostatin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
2670919019	Somatostatin-14	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2656251000005115	Somatostatin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)